Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Desmocollin 1 and 3 have distinct patterns in human tissues, with Dsc1 in specific skin and hair layers and Dsc3 in various epithelial layers.

High levels of human keratin 16 in mice cause skin lesions and abnormal skin development.

Basonuclin helps keratinocytes multiply and prevents them from fully maturing.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Skin cells and certain hair follicle areas produce hemoglobin, which may help protect against oxidative stress like UV damage.

Horse skin has a layered epidermis, a dermis with hair follicles, sweat and sebaceous glands, and is supplied by small arteries.

Skin cancer involves complex mechanisms, risk factors, and can be potentially prevented with strategies like dietary changes and certain compounds.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Sciellin is a protein that helps form protective layers in skin, hair, and nails.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

SOX4 is crucial for the development of melanoma.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

The skin is the body's largest organ, with layers, cells, and structures that protect and support it.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

The Indian buffalo teat has a melanin-rich epidermis, no hair follicles, and a complex structure with muscle, blood vessels, and immune cells.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Enlarged sweat gland ducts may indicate scarring hair loss.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

EGFR inhibitors can cause unusual localized hair growth.